Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
CF Industries (CF) Reports Election of Javed Ahmed to Board
-
Global IDTechEx Research on Emerging Applications for Electronic Skin Patches
-
BeyondSpring (BYSI) Reports Phase 3 Study 105, Evaluating Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
-
Stanford University Reports FY2018 Financial Results
-
Northrim BanCorp (NRIM) Announces Aaron M. Schutt to Board
-
A Healthier WE Announces Inaugural Healthier Rural West Summit
-
BioTime (BTX) Announces Publication of Positive Preclinical Results Utilizing Proprietary HyStem Platform in Ischemic Stroke
-
Sesen Bio (SESN) Appoints Dennis Kim, M.D., MPH, as CMO
-
Western Digital (WDC) Names Kimberly Alexy and Stephanie Streeter to Board
-
Jazz Pharmaceuticals (JAZZ) Reports First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for Treatment of Idiopathic Hypersomnia
-
Form 4 GLEN BURNIE BANCORP For: Oct 03 Filed by: Hess Stanford
-
Form 3 GLEN BURNIE BANCORP For: Aug 09 Filed by: Hess Stanford
-
Fed's Clarida Comments on Data Dependence and U.S. Monetary Policy
-
Rocket Pharmaceuticals (RCKT) Granted FDA Regenerative Medicine Advanced Therapy & Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia
-
Luxfer Holdings plc (LXFR) Names Richard Hipple to Board
-
Luxfer Announces Appointment of Richard Hipple to Board of Directors
-
Tenax Therapeutics (TENX) Reports Activation of First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
-
Stanford Neuroscientist Karl Deisseroth Receives Japan’s Kyoto Prize in Advanced Technology
-
CVS Health (CVS) Releases Statement on FDA Decision to Restrict Flavored Tobacco Products
-
ADT Corp. (ADT) Names Tracey Griffin to Board
-
Jazz Pharmaceuticals (JAZZ) Reports Submission of Marketing Authorization Application to European Medicines Agency for Solriamfetol
-
Denali Therapeutics (DNLI) Announces Jennifer Cook to Board
-
Choice Hotels (CHH) Reports Election of Maureen Sullivan to Board
-
Xencor (XNCR) Names Ellen G. Feigal M.D. to Board
-
Templeton World Charity Foundation Announces First Recipient of 2019 Templeton–Ramanujan Fellowship
-
Rocket Pharmaceuticals (RCKT) Reports FDA Clearance of IND Application for RP-L102 Gene Therapy for Fanconi Anemia
-
Callaway Golf (ELY) Appoints Laura J. Flanagan to Board
-
Stanford Children's Health names Paul King President and CEO
-
Jazz (JAZZ) Announces FDA Approval of Xyrem for Treatment of Cataplexy or EDS in Pediatric Narcolepsy Patients
-
EyePoint Pharmaceuticals (EYPT) Highlights Positive YUTIQ 24-Month Follow-Up Data at AAO 2018 Annual Meeting
-
MasterCraft (MCFT) Names Jaclyn Baumgarten to Board
-
Stanford Inn Offers New Thanksgiving Traditions Featuring Travel, Compassion and Gourmet Plant-Based Cuisine
-
Stanford Medical Pioneers Form Katexco Pharmaceuticals to Develop Innovative CBD Therapies to Treat Inflammatory Diseases
-
BeyondSpring (BYSI) Announces Efficacy and Safety Data from Phase 2 Study 106 with Plinabulin for CIN Prevention
-
Saatchi Art's The Other Art Fair Los Angeles Announces Its Fall 2018 Artist Lineup and Programming
-
Saatchi Art's The Other Art Fair Los Angeles Announces Its Fall 2018 Artist Lineup and Programming
-
NCHL Honors "BOLD" Organizations For Their Evidence-Based Leadership Development Practices
-
Form 4 Energy XXI Gulf Coast, For: Oct 18 Filed by: SPRINGEL STANFORD
-
Harmonic (HLIT) Announces Deborah Clifford to Board
-
Eastside Distilling, Inc. (EAST) Appoints Pat Crowley to Board
-
Form MA-W Southwest Stanford Group
-
Eiger BioPharmaceuticals (EIGR) Reports Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia
-
BeyondSpring (BYSI) Says Lead Asset, Plinabulin, Prevents Docetaxel CIN Due to Mechanism of Action Differentiated from G-CSF
-
Delcath Systems (DCTH) Announces Expansion of Rollout for Registration Trial in Metastatic Ocular Melanoma
-
Krystal Biotech (KRYS) Reports Positive Interim Results from Placebo-Controlled Phase 1/2 Clinical Trial of KB103
-
TG Therapeutics (TGTX) Highlights Final Phase 2 Multicenter Trial of ublituximab (TG-1101) in Multiple Sclerosis Data Presentation
-
Stanford Seed Announces Inaugural Seed Transformation Network Global Summit in Nairobi, Kenya
-
Shimmering Zen: Different Way to View Las Vegas Landmarks, Neon in new Digital Photo Book & Exhibit -Book launch at Neon Museum Studio Oct. 13, Library Show thru Nov. 24-
-
Infinera (INFN) Announces Appoints David Heard as COO
-
Luxfer Declares Quarterly Dividend

